EQA-17505-23016
2 vaccinations
2 coded responses
10 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 481 / MI
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Registered in v-safe
-
2021-01-15
Dose 1 — Pfizer-BioNTech
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-21
-
2021-02-05
Dose 2 — Pfizer-BioNTech
- 2021-02-05
-
2021-02-07
Survey response — days 1–6 daily, dose 2MedDRA: Emergency care, Heart rate increased, Hospitalisation, Laboratory test normal — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Get care from a doctor or other healthcare professional · HospitalizationFree text: Systemic reaction (other): Developed rapid heart rate, 200 BPM, approximately 14 hours after injection requiring hospital stay · Healthcare visit (other): As previously mentioned, rapid heart rate of 200 BPM 14 hours after vaccination. Monitored in ER and admitted to observation as HR remained 120s at rest despite rehydration and labs within normal limits.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-07
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-15
-
2021-08-08
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2022-02-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Pfizer-BioNTech | |
| 2 | 2021-02-05 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Developed rapid heart rate, 200 BPM, approximately 14 hours after injection requiring hospital stay
Healthcare visit (other): As previously mentioned, rapid heart rate of 200 BPM 14 hours after vaccination. Monitored in ER and admitted to observation as HR remained 120s at rest despite rehydration and labs within normal limits.
Release 9 — 6 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Emergency care | ✓ | ✓ | ✓ |
| HCVO | Heart rate increased | ✓ | ✓ | ✓ |
| HCVO | Hospitalisation | ✓ | ✓ | ✓ |
| HCVO | Laboratory test normal | ○ | ✓ | ○ |
| SD | Pregnancy | ✓ | · | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
| SRO | Hospitalisation | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release